Efficacy and safety of secukinumab for the treatment of severe ABCA12 deficiency‐related ichthyosis in a child

Yogarajah, J.; Gouveia, C.; Iype, J.; Häfliger, Stefanie; Schaller, A.; Nuoffer, J. M.; Fux, M.; Gautschi, M. (2021). Efficacy and safety of secukinumab for the treatment of severe ABCA12 deficiency‐related ichthyosis in a child. Skin health and disease, 1(2), e25. Wiley 10.1002/ski2.25

[img]
Preview
Text
ski2.25.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (546kB) | Preview

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Human Genetics
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine

UniBE Contributor:

Gouveia, Carolina, Iype, Joseena Mariam, Häfliger, Stefanie, Schaller, André, Nuoffer, Jean-Marc, Fux, Michaela, Gautschi, Matthias

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2690-442X

Publisher:

Wiley

Language:

English

Submitter:

Anette van Dorland

Date Deposited:

13 Aug 2021 15:28

Last Modified:

07 Jan 2024 01:51

Publisher DOI:

10.1002/ski2.25

PubMed ID:

35664977

BORIS DOI:

10.48350/157828

URI:

https://boris.unibe.ch/id/eprint/157828

Actions (login required)

Edit item Edit item
Provide Feedback